Contract 75H71023F80303
Roche Diabetes Care Inc · Department Of Health And Human Services · May 31, 2023
Roche Diabetes Care Inc was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on May 31, 2023 for $740,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Gallup, NM. This is a task or delivery order issued under parent IDIQ V797D50597. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 29, 2024.
Contract details
- PIID
- 75H71023F80303
- Parent IDIQ
- V797D50597
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Gallup, NM
- First action
- May 31, 2023
- Latest action
- August 29, 2024
Description
DE-OBLIGATE AND CLOSE OUT
Modification timeline
-
August 29, 2024Mod P00002$-45
-
November 15, 2023Mod P00001ADD FUNDS$139.8K
-
May 31, 2023Base awardESTABLISHMENT OF BULK-FUNDED PO$600.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71023F80303?
Contract 75H71023F80303 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Health And Human Services on May 31, 2023 for $740,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75H71023F80303?
Roche Diabetes Care Inc won contract 75H71023F80303 from Department Of Health And Human Services.
How much is contract 75H71023F80303 worth?
Contract 75H71023F80303 has obligated $740,000 to date.